top of page

VIVEbiotech announces significant growth in 2023

San Sebastián, Spain, December 14, 2023 - VIVEbiotech, S.L., a GMP contract development and manufacturing organization (CDMO) full specialized in lentiviral vectors (LVVs), today announced significant growth in 2023, with sales increasing by 70%.


留言


bottom of page